Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Palliation
Is it safe to give localized palliative spinal radiation with concurrent intrathecal cytarabine? If so, do doses need to be adjusted?
Answer from: Radiation Oncologist at Community Practice
In past cases, we have avoided doing this due to concerns of excessive toxicity.
Sign in or Register to read more
218
Related Questions
Would you offer SRS to a hippocampal metastasis in a patient with ES-SCLC treated with prior WBRT?
What screening tools or signs do you use to predict if a cancer patient is near end-of-life?
What is the optimal management of pain and loss of function due to pathologic compression fractures?
How would you manage a patient with bilateral adrenal metastasis if SBRT is not an option?
Do you constrain heterogeneity or hotspots when delivering spine SBRT for bone metastases?
What is the expected timeframe for the development of radiation myelitis and therapies that have helped with neurologic symptoms?
Is it safe to re-irradiate non-spine bone metastases with SBRT if they received previous SBRT?
Does your choice of dose and fractionation for bone metastasis depend on the location of the metastasis in question?
Would you offer a third course of palliative radiation after two courses of 8 Gy in 1 fx?
What normal tissue dose constraints do you use when delivering up to 3 cycles of the palliative quad shot regimen for gynecologic pelvic malignancies?